This year marks the second year of CMS’ electronic prescribing incentive program for office-based physicians.
Meet the Model Biologics Policy
At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.
Industry Support & Quality Initiatives
How the ACR manages conflict-of-interest policies
Breaking Down Medical Decision Making
The medical decision making (MDM) of an evaluation and management visit is just one part of a patient’s visit. Rheumatologists can make the mistake of thinking that the level of visit can be determined just by the MDM, but that is often not the case.
Registries and Rheumatology Quality
The RCR has short- and long-term benefits for the subspecialty
Colcrys Approval Triggers Questions
Some rheumatologists question the depth of research and the approval’s implications for patient access
What Can Clinical Decision Support Do for You?
The current health system places increasing pressure on physicians and their practices to find new and innovative ways to maximize reimbursement through the implementation of programs and workflows that ensure the delivery of higher quality care—all while the ever-increasing needs of the patient population are placing a greater demand on physician time.
Bridge the Gap Between Goal and Attainment
Use motivational interviewing to facilitate behavior change for your clients
HHS Enforces Stricter Rules on HIPAA
As of February 17, 2010, entities covered by the Health Insurance Portability and Accountability Act of 1996 (HIPAA), such as group health plans and their business associates, will have to take certain actions to ensure continued compliance with the privacy and security provisions of the act.
Omeract How to Get into the “Act”
Meet this international organization that focuses on rheumatology outcome measures
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 24
- Next Page »